Trial intelligence / Profile preview

Continuous fluorouracil + mitomycin C vs mitomycin C + cisplatin in chemoradiotherapy for locally advanced anal cancer

2004-000329-31Phase 3Completed

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in anal cancer and anal neoplasm comparing fluorouracil + mitomycin C with radiotherapy with mitomycin C + cisplatin with radiotherapy (2 arms). Started Feb 2007; status: completed.

02

Drugs

fluorouracilmitomycin ccisplatin
03

Conditions

anal canceranal neoplasm

Beyond the preview

Go deeper on 2004-000329-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-000329-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call